Trials / Sponsors / 101 Therapeutics
101 Therapeutics
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | 101-PGC-005 for the Treatment of COVID-19 COVID-19 | Phase 2 | 2023-01-31 |
| Unknown | Study to Evaluate Pharmacokinetics, Safety & Tolerability of 101-PGC-005 in Healthy, Adult, Human Subjects Glucocorticoids Toxicity, COVID-19, Infectious Disease | Phase 1 | 2022-10-29 |
| Terminated | A Prospective, Phase II Study to Evaluate Safety of 101-PGC-005 ('005) for Moderate to Severe COVID-19 Disease COVID-19 | Phase 2 | 2022-01-13 |